Company
Syndeio
Reimagining brain health through new insights into synaptic biology
Also known as Syndeio Biosciences
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Syndeio Biosciences
Claim, correct or request removal
Record updated 28 September 2026
About
Syndeio is a synapse-focused biotech pioneering a new class of therapies for neuropsychiatric and cognitive disorders.
Products
- Other
- Apimostinel
- Other
- Zelquistinel
Loading relationship preview